United States· US:70954-255_987b3eb2-8e19-4ad6-bfdd-670b511d8dd6
Methyltestosterone
A methyltestosterone product containing methyltestosterone, registered in United States by ANI Pharmaceuticals, Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Methyltestosterone is registered in 3 of 19 countries.
Countries holding a registration under ATC G03BA02 (methyltestosterone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Methyltestosterone · ATC G03BA02
3 / 19 countries
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHYLTESTOSTERONE
- Manufacturer
- ANI Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- G03BA02
- ATC class
- Methyltestosterone
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117095425510100 CAPSULE in 1 BOTTLE (70954-255-10)
- ndc1170954-255-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
76 interactions on record for methyltestosterone.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methyltestosterone · interactions on record
76 records
- 8 severe
- 68 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methyltestosterone in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55fb7054-6461-48b3-91c6-25abfd0625fd GET /v1/drugs/55fb7054-6461-48b3-91c6-25abfd0625fd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "METHYLTESTOSTERONE",
"productndc": "70954-255",
"dosage_form": "CAPSULE",
"dea_schedule": "CIII",
"strength_unit": "mg/1",
"application_number": "ANDA215270",
"marketing_category": "ANDA"
}See everything about methyltestosterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.